The CR1-S isoform, which increases AD risk, has more ligand-binding sites but also leads to decreased overall expression; therefore, it is unclear whether CR1 activation is beneficial or deleterious for AD risk [104, 113, 114]. This evidence concerns the gene CR1 and Alzheimer disease.